U.S. Trade Distributors Stock News

Hecla Mining (HL) shares are in focus after the company reported second quarter 2026 exploration results that extended high grade silver mineralization at Keno Hill and revealed new gold and silver veins at Midas. See our latest analysis for Hecla Mining. Despite the positive drilling news, Hecla Mining’s recent share price return has been weak. The stock is down 21.82% over 90 days and 25.17% year to date, while the 1 year total shareholder return above 100% and solid multi year total...

In the past week, Terex Corporation filed new shelf registrations covering up to US$199.104 million of common stock for an ESOP-related offering and a broad mix of securities, shortly after reporting Q2 2026 sales of US$2,238 million and net income of US$110 million. An interesting contrast is that despite higher quarterly sales and net income, Terex’s basic earnings per share slipped year over year, while the company also ended a prior buyback program without repurchasing additional shares...

Recently, Tennessee Valley Authority and ENTRA1 Energy announced non-binding plans to deploy up to six plants totaling as much as 6 gigawatts using NuScale Power’s NRC-certified small modular reactor technology. This prospective multi-plant program highlights how NuScale’s regulatory lead and expanding project pipeline could become crucial tests of whether small modular reactors can be built at scale and on workable budgets. We’ll now examine how this large but non-binding TVA and ENTRA1...

Clover Health Investments has delivered a very strong 215.9% return over the past three years, yet the broader valuation checks still suggest the stock screens as undervalued on several fronts. The share price pullback over the past month sits against solid multi year gains and a high value score that points to a market price that may not fully reflect the underlying fundamentals. Over three years, Clover Health Investments has returned 215.9%, which puts a spotlight on whether recent gains...

AvalonBay Communities and Equity Residential have agreed to merge as equals and have introduced Vivmark Residential as the new combined company name. The merger will create one of the largest multifamily residential real estate companies in the sector. The announcement is drawing attention because of its scale and the potential impact on competition and investor focus in residential REITs. AvalonBay Communities, ticker NYSE:AVB, is entering this merger with a recent share price of $185.61...

Amdocs (DOX) has drawn fresh attention after reporting a 12 month backlog of about $4.28b, supported by new customer agreements for its agentic operating system and the completion of the Matrixx Software acquisition. See our latest analysis for Amdocs. Despite recent contract wins and the Matrixx Software acquisition, Amdocs’ share price return has been mixed. The stock recorded a 7-day gain of 6.95% and a 30-day rise of 8.87%, set against a year-to-date decline of 30.49% and a 1-year total...

Cooling signals from the Fed’s preferred inflation gauges, including the Dallas Fed trimmed mean dropping to 1.4% in June, are giving growth investors a fresh data point to think about. Inflation is still above the Fed’s 2% target on traditional measures and some officials remain hawkish, so the rate path is not yet settled. That mix of softer alternative readings and firm policy talk can matter a lot for growth stocks with strong expansion plans. This article looks at 3 stocks from our...

Corporación América Airports stock has logged a very large 5 year gain while its valuation checks still point to shares that screen as inexpensive on several measures, which raises the question of how much of that performance is already reflected in today’s price. The stock has returned about 370.3% over 5 years, which puts a lot of focus on whether recent fundamentals and expectations justify that kind of long run. Future cash flow growth can support the current share price if margins and...

Recently, Matson’s shares formed a hammer candlestick pattern after a period of selling pressure, a technical signal often interpreted as potential support for the stock. At the same time, analysts have been raising their earnings estimates for Matson, suggesting improving confidence in the company’s profit outlook. Next, we’ll examine how the hammer pattern and rising earnings estimates may affect Matson’s investment narrative and perceived resilience. AI is about to change healthcare...

MGM Resorts International (MGM) just reported second quarter 2026 results, with higher net income and earnings per share from continuing operations compared with a year earlier, alongside a significant goodwill impairment charge. See our latest analysis for MGM Resorts International. MGM Resorts International shares trade at US$44.57 after easing 6.21% over the past month. However, the 90 day share price return of 15.77% and 1 year total shareholder return of 24.67% still point to improving...

Brookfield Infrastructure Partners L.P. recently reported its second-quarter 2026 results, with sales rising to US$6,482 million from US$5,429 million a year earlier, while posting a net loss of US$24 million and maintaining its regular quarterly distribution of US$0.455 per unit. Despite moving from a small profit to a loss over the first half of the year, Brookfield Infrastructure Partners continued to declare both common and preferred distributions, underlining management’s emphasis on...

Merck stock has more than doubled over the past five years, yet the latest valuation checks send a mixed message, with the Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market based multiples look closer to in line. Merck has returned 101.7% over 5 years, which puts the current share price in a very different place to where long term holders started. Progress on products such as the once monthly HIV PrEP candidate alimatravir and expanded use of KEYTRUDA can support...

German American Bancorp, Inc. reported past second-quarter 2026 results showing net interest income of US$81.21 million and net income of US$38.17 million, alongside a regular quarterly dividend declaration of US$0.31 per share payable on August 20, 2026. An interesting insight for shareholders is that stronger earnings coincided with lower net charge-offs of US$673,000 compared with US$848,000 a year earlier, supporting the company’s dividend-paying capacity. We’ll now examine how German...

In late July 2026, Rush Street Interactive, Inc. reported second-quarter 2026 results showing sales of US$393.78 million, net income of US$11.55 million, and basic earnings per share from continuing operations of US$0.10, alongside higher six-month sales of US$764.14 million and net income of US$20.62 million compared with the prior year period. The company also raised its full-year 2026 revenue guidance to a range of US$1.56 billion to US$1.60 billion, highlighting confidence in online...

Smithfield Foods stock has gained 17.6% year to date, yet a fresh look at the numbers suggests the market price may still sit below what its cash flows imply. Both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to Smithfield Foods trading on the cheap side rather than fully priced. Year to date, Smithfield Foods is up 17.6%, which means recent buyers have already seen a solid return even before considering any valuation gap. The key support...

In July 2026, GE Vernova reported Q2 2026 results showing revenue of US$11,104 million and net income of US$668 million, with both basic and diluted earnings per share from continuing operations increasing versus a year earlier. Alongside this earnings release, the company disclosed it had completed a very large US$6,962.92 million share repurchase program that retired 4.57% of its shares, amplifying earnings per share growth. Next, we’ll consider how robust revenue growth alongside an...

TransMedics Group stock has more than doubled over the past five years, yet the broader valuation checks still lean cheap, which puts fresh attention on whether the recent pullback has gone too far or not far enough. Over the past five years, TransMedics Group has returned about 150.4% which keeps the long term story attractive even after a weaker recent stretch. Future execution on transplant system adoption can support higher earnings power. However, any slowdown in procedure volumes or...

Charter Communications stock is coming off a steep multi‑year slide, yet the broader valuation checks still suggest the shares lean cheap rather than expensive at current levels. Over the past 5 years the share price has declined about 81%, which puts a heavy focus on whether today’s lower valuation offers compensation for that drawdown. On the fundamental side, investor expectations around broadband subscriber trends and the pending Cox Communications acquisition can support the equity...

Deluxe has delivered a strong 75.2% return over the past year, yet the broader valuation checks still suggest the stock screens as cheap rather than stretched at the current US$25.87 share price. The 75.2% one year gain puts Deluxe among the stronger recent performers. This can raise the bar for what now counts as a reasonable entry price. The recently closed acquisition of Celero Commerce may support expectations for a larger payments platform, while the risk is that integration hurdles or...

Evercore (EVR) drew fresh attention on July 29, 2026 after reporting second quarter and first half earnings, alongside a new quarterly dividend declaration. This gave investors updated clues about profitability, revenue mix, and capital returns. See our latest analysis for Evercore. Evercore shares closed at US$320.56 on July 31, 2026, with the 1-day share price return of 2.46% coming after the latest earnings and dividend news. The 1-year total shareholder return of 10.17% sits against a...

CRISPR Therapeutics has delivered a steep share price decline of about 64.9% over the past 5 years, yet on broad valuation checks the stock now looks closer to fairly valued than like a clear bargain or clear bubble. The roughly 64.9% slide over 5 years highlights how much long term shareholders have given up in returns, which naturally raises the bar for any new investment case. Progress on CRISPR Therapeutics' allogeneic CAR-T programs, including the Phase 1 work on CTX112 aimed at off the...

InnovAge Holding (INNV) has filed a shelf registration for up to US$1.31 billion of common stock, covering 112,988,070 shares. This filing gives the company scope to raise equity capital when conditions appear suitable. See our latest analysis for InnovAge Holding. The shelf registration arrives after a strong period for InnovAge Holding, with the share price up 36.54% over 90 days and a year to date share price return of 118.88%. The 1 year total shareholder return of 262.94% points to...

Uranium Royalty Corp. recently reported full-year 2026 results showing sales of US$186.81 million and net income of US$40.25 million, and later filed a Form 15 to voluntarily deregister its common shares with the SEC under the Exchange Act. Together with the withdrawal of its CAD$150 million shelf registration and an upcoming CFO change, these actions point to a meaningful shift in how the company manages capital access and regulatory obligations. Next, we will examine how the strong...

In late July 2026, Western Alliance Bancorporation’s board declared a quarterly US$0.42 common dividend and a US$106.25 per share Series A preferred dividend alongside second-quarter results showing higher net interest income and net income than a year earlier. The combination of rising quarterly earnings, lower net loan charge-offs compared with the prior quarter, and continued share repurchases underpins a picture of active capital management and shareholder returns at the bank. We’ll now...